Rapid Dipstick Test for Detection of phIGFBP-1 in Cervical Secretion as Pre-Term Birth Risk Factor
- UID
- MFG/MD/2020/000208_dbd45e732a89c1580905f65627f4ce0f_df4e4bbced3e4acc3753501d48b2ac86
- Device class
- Class B
- Brand name
- EzDx Actim Partus
- License holder
- ADVY CHEMICAL PVT. LTD.
- Approving authority
- Kokan Division
- Product information
- Actim Partus is a visually interpreted, qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 (EzDx Actim Partus ) in cervical secretions during pregnancy. The test is intended for professional use to help predict the risk of preterm or imminent delivery when fetal membranes are intact. A negative test result is a clear indication that the patient will not deliver within 7-14 days
Rapid Dipstick Test for Detection of phIGFBP-1 in Cervical Secretion as Pre-Term Birth Risk Factor is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000208_dbd45e732a89c1580905f65627f4ce0f_df4e4bbced3e4acc3753501d48b2ac86. This device is marketed under the brand name EzDx Actim Partus . The license holder is ADVY CHEMICAL PVT. LTD., and it is classified as Device Class Class B. The approving authority is Kokan Division.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.